Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

November 2, 2018

Study Completion Date

November 2, 2018

Conditions

Multiple Sclerosis

Interventions

DRUG

GNbAC1

Monoclonal Antibody infused i.v.

OTHER

GNbAC1 Placebo

Equivalent to GNbAC1 Buffer

Trial Locations (1)

Scientia Clinical Research Ltd, Sydney

All Listed Sponsors

lead

GeNeuro Australia PTY Ltd

INDUSTRY

NCT03574428 - Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter